MDNews - Cleveland-Akron-Canton

November/December 2017

Issue link: http://viewer.e-digitaledition.com/i/915879

Contents of this Issue

Navigation

Page 7 of 31

in the knee, two in the elbow and one in the shoulder. He points out that it's indicated for use in any joint but primarily used in the knee. "The patient has to have an isolated loss of cartilage in an area that is 4 cm 2 or less, and everything else has to be normal. There can be no mal-alignment; the patient can't be knock-kneed or bow-legged. If he or she is, that has to be corrected at the same time as the cartilage repair," he explains. "The patient can't have an unstable knee. If he or she is ACL deficient, that has to be corrected at the same time, too," he adds. "They have to have a fairly normal joint space, as well." As for age limitation, there doesn't seem to be any. However, the single-stage procedure is not indicated for patients with total joint disease, degenerative arthritis or osteoarthritis. "It's usually for a sports injury or over-use injury," Dr. Fleissner explains. "A lot of our patients are kids who have been injured playing sports, and they lose cartilage from their knee cap or end of their thigh bone." He points out that the single-stage procedure seems to be working very well so far. In addition to being less traumatic for the patient, it's less expensive than the traditional 2-stage cartilage defect surgery. "I am excited to offer this innovative procedure," he says. "I hope it becomes more prevalent and the standard of care for cartilage defects." For more information, or to refer a patient, call Dr. Paul Fleissner at 330-668-4040. n Single-Stage Autologous Chondrocyte Implantation in the Knee IMAGES COURTESY OF PAUL R. FLEISSNER, JR., MD, CRYSTAL CLINIC ORTHOPAEDIC CENTER, AKRON OH 0 8 ❱❱❱❱❱ C O V E R S T O R Y

Articles in this issue

Archives of this issue

view archives of MDNews - Cleveland-Akron-Canton - November/December 2017